Related Experiment Video
Updated: Jul 11, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
A comparative dataset: Bridging COVID-19 and other diseases through epistemonikos and CORD-19 evidence
Andrés Carvallo1, Denis Parra2, Hans Lobel2
1Centro Nacional de Inteligencia Artificial, Vicuña Mackenna 4686, Macul, Santiago, Región Metropolitana, Chile.
Insights
A new dataset of 20,047 COVID-19 documents aids evidence-based medicine (EBM) by classifying research types. This curated collection supports reliable clinical decisions and public health policy during pandemics.
Area of Science:
- Biomedical Informatics
- Public Health
- Information Science
Background:
- The COVID-19 pandemic highlighted the critical need for accurate information to guide clinical decisions and public health strategies.
- Evidence-based medicine (EBM) relies on the effective identification and evaluation of scientific literature, especially for emerging diseases.
- Accurate classification of biomedical text is fundamental to the EBM process.
Purpose of the Study:
- To introduce a comprehensive, curated dataset of COVID-19-related documents to support evidence-based medicine.
- To provide a valuable resource for classifying biomedical texts pertinent to novel diseases.
- To offer a benchmark for future research in evidence synthesis and information retrieval.
Main Methods:
- A dataset of 20,047 COVID-19 documents was meticulously labeled into five categories: systematic reviews (SR), primary study randomized controlled trials (PS-RCT), primary study non-randomized controlled trials (PS-NRCT), broad synthesis (BS), and excluded (EXC).
- Document details including type, title, abstract, and metadata (PubMed ID, authors, journal, publication date) were collected.
- An additional repository of 427,870 non-COVID-19 documents, also categorized, was compiled as a benchmark.
Main Results:
- The curated dataset contains 20,047 labeled COVID-19 documents, categorized for EBM applications.
- A large repository of 427,870 non-COVID-19 documents is available for comparative analysis and benchmarking.
- The dataset is unique, curated by the Epistemonikos Foundation, and not accessible via standard web scraping.
Conclusions:
- This open-access dataset significantly advances evidence-based medicine by providing a structured resource for COVID-19 research.
- The availability of categorized COVID-19 and non-COVID-19 documents facilitates further research in evidence synthesis and biomedical text classification.
- The dataset is poised to enhance the reliability of information for clinical decision-making and public health policy formulation.
Abstract:
The COVID-19 pandemic has underlined the need for reliable information for clinical decision-making and public health policies. As such, evidence-based medicine (EBM) is essential in identifying and evaluating scientific documents pertinent to novel diseases, and the accurate classification of biomedical text is integral to this process. Given this context, we introduce a comprehensive, curated dataset composed of COVID-19-related documents. This dataset includes 20,047 labeled documents that were meticulously classified into five distinct categories: systematic reviews (SR), primary study randomized controlled trials (PS-RCT), primary study non-randomized controlled trials (PS-NRCT), broad synthesis (BS), and excluded (EXC). The documents, labeled by collaborators from the Epistemonikos Foundation, incorporate information such as document type, title, abstract, and metadata, including PubMed id, authors, journal, and publication date. Uniquely, this dataset has been curated by the Epistemonikos Foundation and is not readily accessible through conventional web-scraping methods, thereby attesting to its distinctive value in this field of research. In addition to this, the dataset also includes a vast evidence repository comprising 427,870 non-COVID-19 documents, also categorized into SR, PS-RCT, PS-NRCT, BS, and EXC. This additional collection can serve as a valuable benchmark for subsequent research. The comprehensive nature of this open-access dataset and its accompanying resources is poised to significantly advance evidence-based medicine and facilitate further research in the domain.
More Related Videos
Related Concept Videos
Statistical Software for Data Analysis and Clinical Trials
Single Nucleotide Polymorphisms-SNPs
Genomics
Evolutionary Relationships through Genome Comparisons
Comparing the Survival Analysis of Two or More Groups

